Environmental Health and Clinical Outcomes in Patients with Idiopathic Pulmonary Fibrosis

被引：0
作者：
Avitzur, N. [1 ]
Noth, E. M. [2 ]
Lamidi, M. [3 ]
Nathan, S. D. [4 ]
Dedent, A. M. [5 ]
Thakur, N. [6 ]
Johannson, K. A. M. [7 ]
机构：
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calif Berkeley, Div Environm Hlth Sci, Sch Publ Hlth, Berkeley, CA 94720 USA
[3] Univ Calgary, Dept Biostat, Calgary, AB, Canada
[4] Inova Fairfax Hosp, Falls Church, VA USA
[5] Univ Calif San Francisco, Pulm & Crit Care Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Univ Calgary, Med, Calgary, AB, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1006
引用
收藏
页数：1
相关论文
共 50 条
[41]   Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis [J].
Cottin, Vincent ;
Spagnolo, Paolo ;
Bonniaud, Philippe ;
Nolin, Maeva ;
Dalon, Faustine ;
Chia, Jenny ;
Kirchgassler, Klaus ;
Kamath, Tripthi ;
Van Ganse, Eric ;
Belhassen, Manon .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 :121-121
[42]   Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry [J].
Hyun J. Kim ;
Laurie D. Snyder ;
Megan L. Neely ;
Anne S. Hellkamp ;
David L. Hotchkin ;
Lake D. Morrison ;
Shaun Bender ;
Thomas B. Leonard ;
Daniel A. Culver .
Lung, 2022, 200 :21-29
[43]   Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone [J].
Kim, Tae Hun ;
Shin, Yune-Young ;
Kim, Hyung-Jun ;
Song, Myung Jin ;
Kim, Yeon Wook ;
Lim, Sung Yoon ;
Lee, Yeon Joo ;
Park, Jong Sun ;
Cho, Young-Jae ;
Lee, Jae Ho ;
Lee, Choon-Taek ;
Kwon, Byoung Soo .
SCIENTIFIC REPORTS, 2022, 12 (01)
[44]   Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry [J].
Kim, Hyun J. ;
Snyder, Laurie D. ;
Neely, Megan L. ;
Hellkamp, Anne S. ;
Hotchkin, David L. ;
Morrison, Lake D. ;
Bender, Shaun ;
Leonard, Thomas B. ;
Culver, Daniel A. .
LUNG, 2022, 200 (01) :21-29
[45]   Change In Forced Vital Capacity And Clinical Outcomes In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients [J].
Nathan, S. D. ;
Reichmann, W. M. ;
Macaulay, D. ;
Yu, Y. F. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[46]   REGIONAL VARIATIONS IN CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH IDIOPATHIC PULMONARY FIBROSIS IN THE UNITED STATES [J].
Fatuyi, M. ;
Harris, C. ;
Vargas, G. Asmar ;
Hernandez, C. Mejia ;
Elabd, H. ;
Yusuf, M. ;
El-Labban, M. ;
Patel, N. ;
Muneer, S. .
CHEST, 2022, 161 (06) :244A-244A
[47]   Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis [J].
Qiu, Ying ;
Zhu, Julia ;
Elpers, Brandon ;
Jiang, Jenny ;
Ogbomo, Adesuwa ;
Mallampati, Rajesh ;
Byrne, Clare ;
Tang, Jackson ;
Fischer, Aryeh .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[48]   Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone [J].
Tae Hun Kim ;
Yune-Young Shin ;
Hyung-Jun Kim ;
Myung Jin Song ;
Yeon Wook Kim ;
Sung Yoon Lim ;
Yeon Joo Lee ;
Jong Sun Park ;
Young-Jae Cho ;
Jae Ho Lee ;
Choon-Taek Lee ;
Byoung Soo Kwon .
Scientific Reports, 12
[49]   Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosis [J].
Bando, Masashi .
RESPIRATORY INVESTIGATION, 2016, 54 (05) :298-304
[50]   Lung Tissue Microbiome Is Associated With Clinical Outcomes of Idiopathic Pulmonary Fibrosis [J].
Yoon, Hee-Young ;
Moon, Su-Jin ;
Song, Jin Woo .
FRONTIERS IN MEDICINE, 2021, 8
12345